US FDA Oncology Leadership Shuffle Moves Patricia Keegan To OCE; Gootenberg Takes On Recruitment
US FDA's reorganization of drug reviews splits Keegan's old OHOP division into two.
US FDA's reorganization of drug reviews splits Keegan's old OHOP division into two.